Article Text

Download PDFPDF
Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature
  1. B Hervier1,
  2. C Pagnoux2,
  3. C Agard1,
  4. J Haroche3,
  5. Z Amoura3,
  6. L Guillevin2,
  7. M A Hamidou1,
  8. for the French Vasculitis Study Group
  1. 1
    Department of Internal Medicine, CHU Nantes, France
  2. 2
    Department of Internal Medicine, Hôpital Cochin, Paris, France
  3. 3
    Department of Internal Medicine, CHU Pitié-Salpétrière, Paris, France
  1. Dr B Hervier, Department of Internal Medicine, CHU Nantes 44093, France; baptiste.hervier{at}chu-nantes.fr

Abstract

Objective: To describe the clinical presentation of the association between pulmonary fibrosis (PF) and systemic vasculitis related to antineutrophil cytoplasmic antibodies (ANCA-V).

Methods: 12 patients (three female, mean age 70.7 years) with ANCA-V associated with “idiopathic” PF were studied retrospectively.

Results: ANCA-V and PF were diagnosed simultaneously in eight cases; PF occurred earlier in three cases and during ANCA-V follow-up in one. No patient had intra-alveolar haemorrhage (IAH). ANCA were myeloperoxidase (MPO)-ANCA in all cases. Seven patients had blood eosinophilia at diagnosis. Two patients died during ANCA-V induction therapy. The respiratory status of five patients worsened and three of them died from exacerbation of end-stage respiratory failure. The five remaining patients had a stable respiratory status.

Conclusion: The association of PF and ANCA-V does not seem to be fortuitous, even though their clinical evolutions are clearly not related. PF was the major cause of death.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests: None.

  • Ethics approval: Ethics committee approval obtained.